SE405966B - Sett att framstella peptider - Google Patents

Sett att framstella peptider

Info

Publication number
SE405966B
SE405966B SE7303498A SE7303498A SE405966B SE 405966 B SE405966 B SE 405966B SE 7303498 A SE7303498 A SE 7303498A SE 7303498 A SE7303498 A SE 7303498A SE 405966 B SE405966 B SE 405966B
Authority
SE
Sweden
Prior art keywords
peptims
produce
way
produce peptims
Prior art date
Application number
SE7303498A
Other languages
English (en)
Swedish (sv)
Inventor
M Fujino
S Kobayashi
M Obayashi
S Shinagawa
T Fukuda
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP47026467A external-priority patent/JPS5025442B2/ja
Priority claimed from JP2874072A external-priority patent/JPS5725540B2/ja
Priority claimed from JP2874172A external-priority patent/JPS5647175B2/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of SE405966B publication Critical patent/SE405966B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0825—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Glp-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/08—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using activating agents
    • C07K1/084—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using activating agents containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
SE7303498A 1972-03-14 1973-03-13 Sett att framstella peptider SE405966B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP47026467A JPS5025442B2 (da) 1972-03-14 1972-03-14
JP2874072A JPS5725540B2 (da) 1972-03-21 1972-03-21
JP2874172A JPS5647175B2 (da) 1972-03-21 1972-03-21

Publications (1)

Publication Number Publication Date
SE405966B true SE405966B (sv) 1979-01-15

Family

ID=27285414

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7303498A SE405966B (sv) 1972-03-14 1973-03-13 Sett att framstella peptider

Country Status (10)

Country Link
US (1) US3870694A (da)
AU (1) AU466760B2 (da)
CA (1) CA998997A (da)
CH (1) CH581097A5 (da)
DK (1) DK129088B (da)
FR (1) FR2176009B1 (da)
GB (1) GB1374379A (da)
HU (1) HU170340B (da)
NL (1) NL175522C (da)
SE (1) SE405966B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4126628A (en) * 1977-03-28 1978-11-21 Canadian Patents And Development Limited Acylation of amino acids
US4581168A (en) * 1983-02-21 1986-04-08 Sanofi Synthesis of hpGRF (Somatocrinin) in liquid phase and intermediate peptides
GB2144128B (en) * 1983-07-29 1986-11-26 Sanyo Machine Works The tripeptide eisenin and carcinostatic compositions having an immunopotentiating carcinostatic effect which contain it
US5502165A (en) * 1994-04-04 1996-03-26 Merck & Co., Inc. Process for peptide segment condensation
US6120491A (en) * 1997-11-07 2000-09-19 The State University Rutgers Biodegradable, anionic polymers derived from the amino acid L-tyrosine
JP4312384B2 (ja) 1998-04-13 2009-08-12 ラットガーズ ザ ステイト ユニヴァーシティ コポリマーライブラリーの構築
US7521061B2 (en) * 1999-12-31 2009-04-21 Rutgers, The State University Of New Jersey Pharmaceutical formulation for regulating the timed release of biologically active compounds based on a polymer matrix
CN101472944B (zh) 2006-06-13 2014-05-28 赫里克斯生物医疗公司 用于诱导细胞外基质蛋白合成的肽片段

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1593842A1 (de) * 1967-01-05 1970-08-27 Hoechst Ag Verfahren zur Herstellung von Peptiden

Also Published As

Publication number Publication date
CA998997A (en) 1976-10-26
HU170340B (da) 1977-05-28
FR2176009A1 (da) 1973-10-26
AU466760B2 (en) 1975-11-06
NL175522C (nl) 1984-11-16
FR2176009B1 (da) 1977-08-12
NL175522B (nl) 1984-06-18
AU5308773A (en) 1974-09-12
DK129088B (da) 1974-08-19
CH581097A5 (da) 1976-10-29
US3870694A (en) 1975-03-11
GB1374379A (en) 1974-11-20
NL7303589A (da) 1973-09-18

Similar Documents

Publication Publication Date Title
SE406554B (sv) Sett att framstella mikropartiklar
SE415182B (sv) Sett att framstella platinakoordinationsforeningar
SE7614680L (sv) Sett att framstella nya bensodiazepinderivat
SE411349B (sv) Sett att framstella nya penicilliner
SE417982B (sv) Sett att framstella cefalosporinforeningar
SE417089B (sv) Sett att framstella en sulfonamidoarylforening
SE8205332D0 (sv) Sett att framstella hoghallfast stalband
SE382215B (sv) Sett att framstella kromanderivat
SE391181B (sv) Sett att framstella kinazolinderivat
SE399255B (sv) Sett att framstella kinazolinonderivat
SE386164B (sv) Sett att framstella nya 2-alkylamino-dihydropyridiner
SE7603277L (sv) Sett att framstella prostansyraderivat
SE417211B (sv) Sett att framstella indenyl-3-acetoglucuronider
SE417981B (sv) Sett att framstella cefalosporinforeningar
SE381651B (sv) Sett att framstella karbamater
SE405966B (sv) Sett att framstella peptider
SE399270B (sv) Sett att framstella spirolaktonsteroider
SE381257B (sv) Sett att framstella rifamycinderivat
SE400078B (sv) Sett att framstella kinazolinonderivat
SE397679B (sv) Sett att framstella kinazolinonderivat
SE381831B (sv) Sett att tillverka kylare
SE399712B (sv) Sett att framstella pregnansyraderivat
SE392204B (sv) Sett att framstella jordnotsmjol
SE400281B (sv) Sett att framstella kinazolinonderivat
SE389443B (sv) Sett att framstella en fergad fodoemneskomposition